|
Wednesday 9th August 2017 |
Text too small? |
Blis Technologies chief financial officer Tim Mepham has stepped down as the probiotics maker edges closer to turning a profit.
The Dunedin-based company said Mepham will leave "in the coming months to pursue other business interests" and it is searching for a full-time replacement. Mepham has been performing the role four days a week, it said.
Last month, Blis said it expects to post a maiden profit in the current financial year. The company, which was set up to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu, reported a net loss of $24,000 in the 12 months ended March 31, narrowing from a loss of $816,000 a year earlier.
Blis had forecast a profit for the 2017 financial year but warned the market in February that pre-tax profit wasn't going to meet the $700,000 forecast due to significant reductions in purchases by three major customers.
The stock last traded at 3.5 cents and has shed 13 percent this year.
(BusinessDesk)
No comments yet
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained
TRU - TruScreen Completes Oversubscribed Placement
EROAD Continues Transformation, Reports FY26 Results
May 25th Morning Report
EROAD Appoints New Director Progressing Board Renewal
OCA delivered record full year result
BLT - Strong revenue and underlying earnings growth